The limited availability of hepatic tissue suitable for the treatment of liver disease and drug research encourages the generation of hepatic-like cells from alternative sources as support for the regenerative medicine. Human Blood Derived Stem Cells (BDSCs) express surface markers and genes characteristic of pluripotent stem cells and have the ability to differentiate into different cell types, including tissues of endodermal origin (i.e. liver). Therefore they can represent a valuable source of hepatocytes for medicine. In this investigation we exploited a fast hepatic differentiation protocol to generate hepatocyte-like cells from human BDSCs using only Hepatocyte Growth Factor (HGF) and Fibroblast Growth Factor- 4 (FGF-4) as growth factors. The resulting cell population exhibited hepatic cell-like morphology and it was characterized with a variety of biological endpoint analyses. Here, we demonstrate how human BDSCs can be reprogrammed in hepatocyte-like cells by morphological, functional analysis, Reverse Transcriptase (RT)-PCR and Western Blot assay. This study defines a fast and easy reprogramming strategy that facilitates the differentiation of human BDSCs along a hepatic lineage and provides a framework for a helpful source in the stem cells therapy and liver disorders. J. Cell. Physiol. © 2012 Wiley Periodicals, Inc.

Alaimo, G., Cozzoli, E., Marfe, G., Esposito, L., Ranalli, M., Hmada, D., et al. (2013). Blood-derived stem cells (BDSCs) plasticity: In vitro hepatic differentiation. JOURNAL OF CELLULAR PHYSIOLOGY, 228(6), 1249-1254 [10.1002/jcp.24279].

Blood-derived stem cells (BDSCs) plasticity: In vitro hepatic differentiation.

GIORDANO, ANTONIO;
2013

Abstract

The limited availability of hepatic tissue suitable for the treatment of liver disease and drug research encourages the generation of hepatic-like cells from alternative sources as support for the regenerative medicine. Human Blood Derived Stem Cells (BDSCs) express surface markers and genes characteristic of pluripotent stem cells and have the ability to differentiate into different cell types, including tissues of endodermal origin (i.e. liver). Therefore they can represent a valuable source of hepatocytes for medicine. In this investigation we exploited a fast hepatic differentiation protocol to generate hepatocyte-like cells from human BDSCs using only Hepatocyte Growth Factor (HGF) and Fibroblast Growth Factor- 4 (FGF-4) as growth factors. The resulting cell population exhibited hepatic cell-like morphology and it was characterized with a variety of biological endpoint analyses. Here, we demonstrate how human BDSCs can be reprogrammed in hepatocyte-like cells by morphological, functional analysis, Reverse Transcriptase (RT)-PCR and Western Blot assay. This study defines a fast and easy reprogramming strategy that facilitates the differentiation of human BDSCs along a hepatic lineage and provides a framework for a helpful source in the stem cells therapy and liver disorders. J. Cell. Physiol. © 2012 Wiley Periodicals, Inc.
File in questo prodotto:
File Dimensione Formato  
Blood-derived stem cells (BDSCs) plasticity in vitro hepatic differentiation.pdf

non disponibili

Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 4.99 MB
Formato Adobe PDF
4.99 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11365/44102
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo